Literature DB >> 4150929

Plasma and cerebrospinal fluid concentrations of pentazocine in patients: assay by mass fragmentography.

S Agurell, L O Boréus, E Gordon, J E Lindgren, M Ehrnebo, U Lönroth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4150929     DOI: 10.1111/j.2042-7158.1974.tb12811.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  7 in total

Review 1.  Pharmacokinetics in intravenous anaesthetic practice.

Authors:  P Duvaldestin
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of narcotic agonist-antagonist drugs.

Authors:  R E Bullingham; H J McQuay; R A Moore
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

3.  Prediction of the volumes of distribution of basic drugs in humans based on data from animals.

Authors:  Y Sawada; M Hanano; Y Sugiyama; H Harashima; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

Review 4.  Clinical pharmacokinetics of cerebrospinal fluid.

Authors:  M Bonati; J Kanto; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

5.  [Detection of pentazocin (Fortral) in human urine: gas chromatographic/mass spectrometric studies].

Authors:  W Gielsdorf; E Klug; M Tümmers
Journal:  Z Rechtsmed       Date:  1982

Review 6.  Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.

Authors:  Y Sawada; M Hanano; Y Sugiyama; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1985-10

7.  Evaluation of the abuse potential of difelikefalin, a selective kappa-opioid receptor agonist, in recreational polydrug users.

Authors:  Megan J Shram; Robert H Spencer; Jenny Qian; Catherine L Munera; Michael E Lewis; Jack E Henningfield; Lynn Webster; Frédérique Menzaghi
Journal:  Clin Transl Sci       Date:  2021-10-28       Impact factor: 4.689

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.